Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : email@example.com
|Title||Perioperative Pembrolizumab and Lenvatinib in Resectable Hepatocellular Carcinoma (HCC) (PRIMER-1)|
|Sponsors||University College, London|
|Age Groups:||adult | senior|
|Queen Elizabeth Hospital||Not yet recruiting||Birmingham||United Kingdom||Details|
|Cambridge University Hospitals NHS Foundation Trust||Not yet recruiting||Cambridge||United Kingdom||Details|
|Beatson West of Scotland Cancer Centre||Not yet recruiting||Glasgow||United Kingdom||Details|
|St James's Hospital, Leeds Teaching Hospital NHS Trust||Not yet recruiting||Leeds||United Kingdom||Details|
|Clatterbridge Cancer Centre||Not yet recruiting||Liverpool||United Kingdom||Details|
|King's College Hospital||Not yet recruiting||London||United Kingdom||Details|
|Royal Free Hospital||Recruiting||London||United Kingdom||Details|
|The Christie NHS Foundation Trust||Not yet recruiting||Manchester||United Kingdom||Details|
|Northern Institute of Cancer Research||Not yet recruiting||Newcastle Upon Tyne||United Kingdom||Details|